Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 2706

1.

Polymorphisms in folic acid metabolism genes do not associate with cancer cachexia in Japanese gastrointestinal patients.

Morishita T, Hishida A, Okugawa Y, Morimoto Y, Shirai Y, Okamoto K, Momokita S, Ogawa A, Tanaka K, Nishikawa R, Toiyama Y, Inoue Y, Sakurai H, Urata H, Tanaka M, Miki C.

Nagoya J Med Sci. 2018 Nov;80(4):529-539. doi: 10.18999/nagjms.80.4.529.

2.

Undiagnosed cardiac deficits in non-small cell carcinoma patients in the candidate population for anti-cachexia clinical trials.

Kazemi-Bajestani SMR, Becher H, Butts C, Basappa NS, Smylie M, Joy AA, Sangha R, Gallivan A, Chu Q, Baracos VE.

Support Care Cancer. 2019 Apr;27(4):1551-1561. doi: 10.1007/s00520-018-4561-y. Epub 2018 Dec 13.

PMID:
30547303
3.

New developments in investigational HDAC inhibitors for the potential multimodal treatment of cachexia.

Penna F, Costelli P.

Expert Opin Investig Drugs. 2019 Feb;28(2):179-189. doi: 10.1080/13543784.2019.1557634. Epub 2018 Dec 14. Review.

PMID:
30526137
4.

Selective Androgen Receptor Modulators: Current Knowledge and Clinical Applications.

Solomon ZJ, Mirabal JR, Mazur DJ, Kohn TP, Lipshultz LI, Pastuszak AW.

Sex Med Rev. 2019 Jan;7(1):84-94. doi: 10.1016/j.sxmr.2018.09.006. Epub 2018 Nov 30. Review.

PMID:
30503797
5.

Local and Systemic Cytokine Profiling for Pancreatic Ductal Adenocarcinoma to Study Cancer Cachexia in an Era of Precision Medicine.

Gerber MH, Underwood PW, Judge SM, Delitto D, Delitto AE, Nosacka RL, DiVita BB, Thomas RM, Permuth JB, Hughes SJ, Wallet SM, Judge AR, Trevino JG.

Int J Mol Sci. 2018 Dec 1;19(12). pii: E3836. doi: 10.3390/ijms19123836.

6.

Pharmacological management of cachexia in adult cancer patients: a systematic review of clinical trials.

Advani SM, Advani PG, VonVille HM, Jafri SH.

BMC Cancer. 2018 Nov 27;18(1):1174. doi: 10.1186/s12885-018-5080-4.

7.

Myokines as Possible Therapeutic Targets in Cancer Cachexia.

Manole E, Ceafalan LC, Popescu BO, Dumitru C, Bastian AE.

J Immunol Res. 2018 Oct 22;2018:8260742. doi: 10.1155/2018/8260742. eCollection 2018. Review.

8.

Progressive resistance training in cachectic head and neck cancer patients undergoing radiotherapy: a randomized controlled pilot feasibility trial.

Grote M, Maihöfer C, Weigl M, Davies-Knorr P, Belka C.

Radiat Oncol. 2018 Nov 6;13(1):215. doi: 10.1186/s13014-018-1157-0.

9.

Efficacy of Anamorelin, a Novel Non-Peptide Ghrelin Analogue, in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) and Cachexia-Review and Expert Opinion.

Currow DC, Maddocks M, Cella D, Muscaritoli M.

Int J Mol Sci. 2018 Nov 5;19(11). pii: E3471. doi: 10.3390/ijms19113471. Review.

10.

Clinical impact of cachexia in unresectable locally advanced head and neck cancer: supplementary analysis of a phase II trial (JCOG0706-S2).

Matsuzuka T, Kiyota N, Mizusawa J, Akimoto T, Fujii M, Hasegawa Y, Iwae S, Monden N, Matsuura K, Onozawa Y, Hayashi R, Tahara M; Japan Clinical Oncology Group(JCOG) Head and Neck Cancer Study Group.

Jpn J Clin Oncol. 2019 Jan 1;49(1):37-41. doi: 10.1093/jjco/hyy145.

PMID:
30364985
11.

Increased serum levels of S100A1, ZAG, and adiponectin in cachectic patients with COPD.

Mokari-Yamchi A, Sharifi A, Kheirouri S.

Int J Chron Obstruct Pulmon Dis. 2018 Oct 8;13:3157-3163. doi: 10.2147/COPD.S172996. eCollection 2018.

12.

ZIP4 Promotes Muscle Wasting and Cachexia in Mice With Orthotopic Pancreatic Tumors by Stimulating RAB27B-Regulated Release of Extracellular Vesicles From Cancer Cells.

Yang J, Zhang Z, Zhang Y, Ni X, Zhang G, Cui X, Liu M, Xu C, Zhang Q, Zhu H, Yan J, Zhu VF, Luo Y, Hagan JP, Li Z, Fang J, Jatoi A, Fernandez-Zapico ME, Zheng L, Edil BH, Bronze MS, Houchen CW, Li YP, Li M.

Gastroenterology. 2019 Feb;156(3):722-734.e6. doi: 10.1053/j.gastro.2018.10.026. Epub 2018 Oct 17.

PMID:
30342032
13.

Cancer cachexia and myopenia - Update on management strategies and the direction of future research for optimizing body composition in cancer - A narrative review.

Pring ET, Malietzis G, Kennedy RH, Athanasiou T, Jenkins JT.

Cancer Treat Rev. 2018 Nov;70:245-254. doi: 10.1016/j.ctrv.2018.10.002. Epub 2018 Oct 6. Review.

PMID:
30321741
14.

The Palliative Radiotherapy and Inflammation Study (PRAIS) - protocol for a longitudinal observational multicenter study on patients with cancer induced bone pain.

Habberstad R, Frøseth TCS, Aass N, Abramova T, Baas T, Mørkeset ST, Caraceni A, Laird B, Boland JW, Rossi R, Garcia-Alonso E, Stensheim H, Loge JH, Hjermstad MJ, Bjerkeset E, Bye A, Lund JÅ, Solheim TS, Vagnildhaug OM, Brunelli C, Damås JK, Mollnes TE, Kaasa S, Klepstad P.

BMC Palliat Care. 2018 Sep 28;17(1):110. doi: 10.1186/s12904-018-0362-9.

15.

Emerging role of extracellular vesicles in mediating cancer cachexia.

Chitti SV, Fonseka P, Mathivanan S.

Biochem Soc Trans. 2018 Oct 19;46(5):1129-1136. doi: 10.1042/BST20180213. Epub 2018 Sep 20. Review.

PMID:
30242118
16.

Myostatin knockout induces apoptosis in human cervical cancer cells via elevated reactive oxygen species generation.

Han YQ, Ming SL, Wu HT, Zeng L, Ba G, Li J, Lu WF, Han J, Du QJ, Sun MM, Yang GY, Wang J, Chu BB.

Redox Biol. 2018 Oct;19:412-428. doi: 10.1016/j.redox.2018.09.009. Epub 2018 Sep 13.

17.

Case 3/2018 - A 60-year-old Female with Chagasic Heart Disease, Admitted Due to Heart Failure Decompensation, Cachexia and Pulmonary Infection.

Arduine GA, Aiello VD.

Arq Bras Cardiol. 2018 Jun;110(6):588-596. doi: 10.5935/abc.20180100. English, Portuguese. No abstract available.

18.

Survival strategies of cancerous cells: a novel perspective.

Sarode SC, Sharma NK, Sarode GS, Nilendu P, Patil S.

Future Oncol. 2018 Nov;14(26):2679-2682. doi: 10.2217/fon-2018-0599. Epub 2018 Sep 7. No abstract available.

19.

Comparison of sarcopenia and cachexia in men with chronic heart failure: results from the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF).

Emami A, Saitoh M, Valentova M, Sandek A, Evertz R, Ebner N, Loncar G, Springer J, Doehner W, Lainscak M, Hasenfuß G, Anker SD, von Haehling S.

Eur J Heart Fail. 2018 Nov;20(11):1580-1587. doi: 10.1002/ejhf.1304. Epub 2018 Aug 30.

PMID:
30160804
20.

Platinum-induced muscle wasting in cancer chemotherapy: Mechanisms and potential targets for therapeutic intervention.

Moreira-Pais A, Ferreira R, Gil da Costa R.

Life Sci. 2018 Sep 1;208:1-9. doi: 10.1016/j.lfs.2018.07.010. Epub 2018 Jul 6. Review.

PMID:
30146014

Supplemental Content

Loading ...
Support Center